C. Bouriel

Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer

Breast cancer

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

¹⁸F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006

Use of new imaging techniques to predict tumour response to therapy

¹⁸F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer

High Prognostic Value of ¹⁸F-FDG PET for Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation

Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis

Radiomics: Extracting more information from medical images using advanced feature analysis

Radiomics: the bridge between medical imaging and personalized medicine

Imaging and cancer: A review

Tensor Regression with Applications in Neuroimaging Data Analysis

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography

Predictive Value of ¹⁸F-FDG PET and Somatostatin Receptor Scintigraphy in Patients with Metastatic Endocrine Tumors